A Phase II/III clinical trial to assess safety and immunogenicity of the Pandemic influenza vaccine (Human, live attenuated) A (H1N1) 2009 of SIIL In Adults, Elderly and Pediatric Populations.

Trial Profile

A Phase II/III clinical trial to assess safety and immunogenicity of the Pandemic influenza vaccine (Human, live attenuated) A (H1N1) 2009 of SIIL In Adults, Elderly and Pediatric Populations.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Adverse reactions
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 11 Jul 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
    • 20 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
    • 10 Mar 2010 Actual initiation date (8 Mar 2010) added as reported by Clinical Trials Registry - India.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top